ArticleBMC gastroenterology2025
MRI findings of confluent hepatic fibrosis caused by different etiologies.
Article in BMC gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundTo identify the magnetic resonance imaging (MRI) features of confluent hepatic fibrosis (CHF) caused by different etiologies.
methodsThe imaging features of 50 patients with CHF on liver MRI were retrospectively analyzed on conventional and contrast-enhanced sequences.
resultsPatients were subgrouped by different etiology (alcoholic liver disease, chronic hepatitis B, drug-induced liver injury, autoimmune hepatitis, primary sclerosing cholangitis, and others). The median age of the patients was 55 years, and 68% were female. On MRI, CHF lesions were predominantly radial and wedge-shaped patches, located in proximity to the second hepatic hilum, and exhibited delayed enhancement. On T1-weighted imaging (T1WI), 94% of CHF lesions presented hypointensity; on T2-weighted imaging (T2WI), diffusion-weighted imaging (DWI), and apparent diffusion coefficient (ADC) maps, most CHF lesions demonstrated mild to moderate hyperintensity. Some lesions also demonstrated diffusely distribution around the vascular (16%) and subcapsular regions (18%), with mild to moderate enhancement on the late arterial phase. 76% of CHF lesions were accompanied by liver cirrhosis, and 62% cases were associated with capsular retraction.
conclusionsThe clinical and MRI characteristics of CHF minimally vary across different etiology of liver disease. CHF lesions predominantly exhibit radial distribution from the second hepatic hilum, accompanied by consistent delayed enhancement and capsular retraction.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.